Survey Finds Older Cardiac Patients Have Different Goals, Lower Risk Tolerance
The survey focused on invasive cardiac care and measured patient knowledge, goals, and concerns related to these procedures.
ADHD Could Present Higher Risk for Nicotine Addiction
Research Network Based at DCRI Awarded up to $102.5M for Work on Antibacterial Resistance
Working at the Intersection of Expertise to Improve Patient Care
New Quadruple Therapy Shows Promise, But More Data are Needed
In a recent editorial in Circulation, the DCRI’s Michael Felker, MD, raises questions that the heart failure field should consider in light of new results from the DAPA-HF trial.
Proteins in Plasma Could Provide Information about IPF Disease Severity
A study of proteins in plasma taken from patients in the IPF-PRO registry found that patients with IPF have a distinct circulating set of proteins and that select proteins correlate well with clini
To Leverage Power of Machine Learning, Focus on Implementation is Needed
With machine learning on the rise, DCRI’s Eric Peterson, MD, MPH, takes a retrospective look at prior efforts to implement risk prediction models and what lessons can be drawn from the past for cur
AHA 2019: DCRI Study Tests Apixaban versus Warfarin in New Patient Population
The exploratory study of patients with atrial fibrillation and on hemodialysis evaluated rates of bleeding when randomized to apixaban versus warfarin.
DCRI Faculty Recognized on Global “Highly Cited” List
Fifty-four researchers from Duke, including nine from the DCRI, were recognized for their high citation rates.
Data Monitoring Committees Need Complete Data to Protect Patients
Data monitoring committees could be provided more and better data in order to fulfill its role of protecting trial participants.